Sponsor:
Pfizer
Code:
NCT07783425
Conditions
Atopic Dermatitis
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Tilrekimig
Dupilumab
Placebo for Tilrekimig
Placebo for Dupilumab
Brief summary:
Conditions
Atopic Dermatitis
Study ID
NCT07783425
Start date
Aug 24, 2026
Status verified date
Nov, 2026
Completion date
Jun 15, 2029
Anticipated
Primary completion date
Sep 8, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Enrollment
1375 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Tilrekimig - Initial treatment period
placebo comparator: Placebo - Initial treatment period
experimental: Tilrekimig - Maintenance Period - Dose B
experimental: Tilrekimig - Maintenance Period - Dose A
active comparator: Dupilumab - Initial treatment period
placebo comparator: Placebo - Maintenance Period
Interventions
Tilrekimig
Dupilumab
Placebo for Tilrekimig
Placebo for Dupilumab
Primary outcome measure
Central contacts
Locations
AllerVie Clinical Research
Recruiting
Birmingham, Alabama, United States, 35209
Alliance Dermatology & MOHS Center
Recruiting
Phoenix, Arizona, United States, 85032
Dermatology Trial Associates, Inc.
Recruiting
Bryant, Arkansas, United States, 72022
Kern Research, Inc.
Recruiting
Bakersfield, California, United States, 93301
Marvel Clinical Research
Recruiting
Huntington Beach, California, United States, 92647
Avance Clinical Trials
Recruiting
Laguna Niguel, California, United States, 92677
California Allergy & Asthma Medical Group
Recruiting
Los Angeles, California, United States, 90025
Northridge Clinical Trials, LLC
Recruiting
Northridge, California, United States, 91325
Direct Helpers Research Center
Recruiting
Hialeah, Florida, United States, 33012
Research Associates of South Florida, LLC
Recruiting
Miami, Florida, United States, 33134
Global Health Research Center, Inc.
Recruiting
Miami Lakes, Florida, United States, 33016
Clinical Neuroscience Solutions, LLC
Recruiting
Orlando, Florida, United States, 32801
Skin Care Physicians of Georgia
Recruiting
Macon, Georgia, United States, 31217
Marietta Dermatology Clinical Research, Inc.
Recruiting
Marietta, Georgia, United States, 30060
Dawes Fretzin Clinical Research Group, LLC
Recruiting
Indianapolis, Indiana, United States, 46250
Maryland Laser Skin and Vein
Recruiting
Hunt Valley, Maryland, United States, 21030
Respiratory Medicine Research Institute of Michigan, PLC
Recruiting
Ypsilanti, Michigan, United States, 48197
Vital Prospects Clinical Research Institute., PC
Recruiting
Tulsa, Oklahoma, United States, 74136
Clinical Neuroscience Solutions, LLC.
Recruiting
Memphis, Tennessee, United States, 38119
Arlington Research Center
Recruiting
Arlington, Texas, United States, 76011
Dermatology Treatment and Research Center
Recruiting
Dallas, Texas, United States, 75230
Derm Texas
Recruiting
Dallas, Texas, United States, 75235
Complete Dermatology
Recruiting
Sugar Land, Texas, United States, 77479
Alexandria Associates in Dermatology
Recruiting
Arlington, Virginia, United States, 22206
Sponsor
Pfizer
Last update posted
Nov 6, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by Pfizer on 2026-11-06. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.